deltatrials
Completed PHASE4 NCT00776828

The Efficacy of CILostazol ON Ischemic Complications After DES Implantation

Influence of CILostazol-based Triple Anti-platelet Therapy ON Ischemic Complication After Drug-eluting stenT Implantation

Sponsor: Seoul National University Hospital

Conditions Coronary Artery Disease
Interventions cilostazol
Updated 6 times since 2017 Last updated: Dec 15, 2013 Started: Nov 30, 2006 Primary completion: Jan 31, 2010 Completion: Jan 31, 2010

Listed as NCT00776828, this PHASE4 trial focuses on Coronary Artery Disease and remains completed. Sponsored by Seoul National University Hospital, it has been updated 6 times since 2006, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Nov 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Seoul National University Hospital
Data source: Seoul National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Seoul, South Korea